MIT finds way to keep RNA vaccines stable at high temperatures

Researchers at MIT have developed a new formulation that helps RNA vaccines withstand high temperatures. The advance could remove the need for ultracold storage that currently limits mRNA vaccines for COVID-19 and other diseases.

• RNA vaccines currently require ultracold storage, limiting their use
• MIT's formulation improves the vaccines' heat stability
• The method could ease vaccination against COVID-19, cancer and more